Drugs recalls

Prescription and over-the-counter drug recalls from FDA enforcement reports: sterility problems, contamination, potency failures and labeling errors.

1,547 recalls published between October 9, 2024 and September 30, 2026. Most common issues: manufacturing practices (cgmp) (523), sterility (291), potency (138), microbial contamination (109). 94 were FDA Class I, the most serious level.

Browse by type (3)